North American Bioproducts Corp.; Filing of Food Additive Petition (Animal Use); Erythromycin Thiocyanate, 21300 [2010-9420]
Download as PDF
<![CDATA[
21300
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Notices
the petition must contain sufficient facts
to merit an FDA investigation. (See H.
Rept. 857, part 1, 98th Cong., 2d sess.,
pp. 41–42, 1984.) Petitions should be in
the format specified in 21 CFR 10.30.
Comments and petitions should be
submitted to the Division of Dockets
Management. Three copies of any
mailed information are to be submitted,
except that individuals may submit one
copy. Comments are to be identified
with the docket numbers found in
brackets in the heading of this
document. Comments and petitions may
be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: March 22, 2010.
Jane A. Axelrad,
Associate Director for Policy, Center for Drug
Evaluation and Research.
[FR Doc. 2010–9509 Filed 4–22–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0159]
North American Bioproducts Corp.;
Filing of Food Additive Petition
(Animal Use); Erythromycin
Thiocyanate
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that North American Bioproducts Corp.
has filed a petition proposing that the
food additive regulations be amended to
provide for the safe use of erythromycin
thiocyanate as an antimicrobial
processing aid in fuel-ethanol
fermentations with respect to its
consequent presence in by-product
distiller grains used as an animal feed
or feed ingredient.
DATES: Submit written or electronic
comments on the petitioner’s
environmental assessment May 24,
2010.
You may submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Isabel W. Pocurull, Center for Veterinary
Medicine, Food and Drug
Administration, 7519 Standish Pl.,
VerDate Nov<24>2008
15:23 Apr 22, 2010
Jkt 220001
Rockville, MD 20855, 240–453–6853,
email: isabel.pocurull@fda.hhs.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Under the
Federal Food, Drug, and Cosmetic Act
(section 409(b)(5) (21 U.S.C. 348(b)(5)),
notice is given that a food additive
petition (FAP 2263) has been filed by
North American Bioproducts Corp.,
Corporate Support Center, 1815 Satellite
Blvd., Building 200, Duluth, GA 30097.
The petition proposes to amend the food
additive regulations in 21 CFR Part 573
Food Additives Permitted in Feed and
Drinking Water of Animals to provide
for the safe use of erythromycin
thiocyanate as an antimicrobial
processing aid in fuel-ethanol
fermentations with respect to its
consequent presence in by-product
distiller grains used as an animal feed
or feed ingredient.
The potential environmental impact
of this action is being reviewed. To
encourage public participation
consistent with regulations issued under
the National Environmental Policy Act
(40 CFR 1501.4(b)), the agency is
placing the environmental assessment
submitted with the petition that is the
subject of this notice on public display
at the Division of Dockets Management
(see ADDRESSES) for public review and
comment.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
FDA will also place on public display
any amendments to, or comments on,
the petitioner’s environmental
assessment without further
announcement in the Federal Register.
If, based on its review, the agency finds
that an environmental impact statement
is not required and this petition results
in a regulation, the notice of availability
of the agency’s finding of no significant
impact and the evidence supporting that
finding will be published with the
regulation in the Federal Register in
accordance with 21 CFR 25.51(b).
Substance Abuse and Mental Health
Services Administration
SUPPLEMENTARY INFORMATION:
Dated: April 14, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010–9420 Filed 4–22–10; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Fiscal Year (FY) 2010 Funding
Opportunity
AGENCY: Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
Single Source Grant to the current
grantee for the National Center for Child
Traumatic Stress.
SUMMARY: This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award
approximately $1,000,000 (total costs)
for up to one year to the current grantee
for the National Center for Child
Traumatic Stress (NCCTS). This is not a
formal request for applications.
Assistance will be provided only to the
current grantee for the National Center
for Child Traumatic Stress based on the
receipt of a satisfactory application that
is approved by an independent review
group.
Funding Opportunity Title: SM–10–
016.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
Authority: Section 582 of the Public
Health Service Act, as amended.
Justification: Only an application
from the current grantee for the National
Center for Child Traumatic Stress will
be considered for funding under this
announcement. One-year funding has
become available to assist SAMHSA in
responding to data analysis and
reporting activities that improve
evidence-based practices and raise the
standard of trauma care. It is considered
most cost-effective and efficient to
supplement the existing grantee because
they have access to the existing National
Child Traumatic Stress Network
(NCTSN) datasets and data analytic
expertise to conduct the required data
analytic activities. There is no other
potential organization with the required
access and expertise.
Eligibility for this program
supplement is restricted to the current
grantee, National Center for Child
Traumatic Stress in accordance with
Congressional intent for 2010 SAMHSA
appropriations.
The role of the NCCTS is to provide
infrastructure and support for the
National Child Traumatic Stress
Network to achieve its goals of
increasing access and raising the
standard of care for traumatized
children, adolescents, and their
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Page 21300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9420]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0159]
North American Bioproducts Corp.; Filing of Food Additive
Petition (Animal Use); Erythromycin Thiocyanate
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that
North American Bioproducts Corp. has filed a petition proposing that
the food additive regulations be amended to provide for the safe use of
erythromycin thiocyanate as an antimicrobial processing aid in fuel-
ethanol fermentations with respect to its consequent presence in by-
product distiller grains used as an animal feed or feed ingredient.
DATES: Submit written or electronic comments on the petitioner's
environmental assessment May 24, 2010.
ADDRESSES: You may submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-453-6853, email: isabel.pocurull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a
food additive petition (FAP 2263) has been filed by North American
Bioproducts Corp., Corporate Support Center, 1815 Satellite Blvd.,
Building 200, Duluth, GA 30097. The petition proposes to amend the food
additive regulations in 21 CFR Part 573 Food Additives Permitted in
Feed and Drinking Water of Animals to provide for the safe use of
erythromycin thiocyanate as an antimicrobial processing aid in fuel-
ethanol fermentations with respect to its consequent presence in by-
product distiller grains used as an animal feed or feed ingredient.
The potential environmental impact of this action is being
reviewed. To encourage public participation consistent with regulations
issued under the National Environmental Policy Act (40 CFR 1501.4(b)),
the agency is placing the environmental assessment submitted with the
petition that is the subject of this notice on public display at the
Division of Dockets Management (see ADDRESSES) for public review and
comment.
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) electronic or written comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday. FDA will also place on public display any amendments
to, or comments on, the petitioner's environmental assessment without
further announcement in the Federal Register. If, based on its review,
the agency finds that an environmental impact statement is not required
and this petition results in a regulation, the notice of availability
of the agency's finding of no significant impact and the evidence
supporting that finding will be published with the regulation in the
Federal Register in accordance with 21 CFR 25.51(b).
Dated: April 14, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010-9420 Filed 4-22-10; 8:45 am]
BILLING CODE 4160-01-S
